Stay updated on Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial

Sign up to get notified when there's something new on the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The website has updated the 'type of intervention' feature from version v2.13.3 to v2.14.0, indicating a significant revision.
    Difference
    1%
    Check dated 2025-01-12T17:36:07.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Difference
    1%
    Check dated 2025-01-05T14:05:26.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    New updates have been added, including a completion date of 2024-12-20 and an actual date of 2024-12-12, while previous entries such as 'Active, not recruiting' and several estimated dates have been removed.
    Difference
    0.7%
    Check dated 2024-12-21T23:09:29.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The website has been updated from version 2.13.2 to 2.13.3.
    Difference
    0.3%
    Check dated 2024-12-14T22:33:14.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The website has updated the contact details section for the study, replacing the previous information with new details and revising the certification dates.
    Difference
    3%
    Check dated 2024-12-07T15:55:02.000Z thumbnail image
  7. Check
    48 days ago
    Change Detected
    Summary
    AbbVie has added new information regarding the IMGN853-0419 study, including a study director and helpful links, while ImmunoGen, Inc. has been removed from the list.
    Difference
    1%
    Check dated 2024-11-30T12:32:55.000Z thumbnail image

Stay in the know with updates to Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mirvetuximab in Platinum-Sensitive Gynecologic Cancer Clinical Trial page.